CN101380409A - Broadspectrum antiphlogistic traditional Chinese medicine - Google Patents
Broadspectrum antiphlogistic traditional Chinese medicine Download PDFInfo
- Publication number
- CN101380409A CN101380409A CNA200710077928XA CN200710077928A CN101380409A CN 101380409 A CN101380409 A CN 101380409A CN A200710077928X A CNA200710077928X A CN A200710077928XA CN 200710077928 A CN200710077928 A CN 200710077928A CN 101380409 A CN101380409 A CN 101380409A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine
- powder
- broadspectrum
- rhizoma paridis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to an anti-inflammatory Chinese medicine with broad spectrum, which is a medicine composite with the broad anti-inflammatory spectrum, in particular to a medicine which is prepared by taking traditional Chinese herbal medicines as raw materials and can cure multiple inflammations. Tinospora Tuber and rhizoma paridis are taken as raw materials, mixed according to certain proportion and prepared into pulvis, suppository and capsule which are respectively referred to 'Diwang Jiedusan', 'Diwang Jiedushuan' and 'Diwang jiedu capsule' and have peculiar healing efficacy on diseases of the urogenital system, and have certain healing efficacy on peptic ulcer, acute bacillary dysentery, acute and chronic cholecystitis. The medicine addresses both the symptoms and root causes, has broad antibiotic spectrum, good drug action, low cost and simple and convenient preparation without any toxic and side effect.
Description
Technical field: the present invention relates to a kind of pharmaceutical composition of Broadspectrum antiphlogistic, the medicine of inflammation is planted by particularly a kind of energy Zhiduo County that with the botanical herbs is raw material is made.
Background technology: Radix Tinosporae is a kind of Chinese medicine that can treat multiple inflammation, according to Xiao Peigen chief editor " newly organized Chinese medicinal herbal ", Chemical Industry Press publishes and the Jiangsu medical college is compiled " Chinese medicine voluminous dictionary ", the books record that Shanghai science tech publishing house publishes, Radix Tinosporae nature and flavor bitter cold, nontoxic; Have heat clearing away, detoxifcation, the flat function of choosing multiple inflammation such as body inflammation, acute pharyngolaryngitis, stomatitis, parotitis, mastitis, appendicitis, carbuncle furuncle, acute chronic enteritis, bacillary dysentery of treatment acute and chronic, to gold-coloured staphylococci, acid-resisting mycobacterium, various pathogens such as tubercule bacillus have inhibitory action clinically.Use Radix Tinosporae separately, often therapeutic effect not too obviously or treatment cycle drag very longly, and be general antiinflammatory, therefore no specific aim often arranges in pairs or groups with other medicines in the use, as above-mentioned books record, when treating mastitis, appendicitis, tonsillitis, stomatitis, parotitis, acute bacillary dysentery with Radix Tinosporae, to cooperate with Herba Sonerilae cantonensis, when controlling carbuncle, cooperate with Herba Sonerilae cantonensis, Herba Xanthii grass with Radix Tinosporae ...Patent of invention " a kind of pharmaceutical composition with antibacterial and anti-inflammation functions ", application number 200510044767.5 is mainly treated upper respiratory tract infection with Radix Tinosporae, cooperates with Herba Houttuyniae or its salt with Radix Tinosporae.More than explanation Radix Tinosporae and other medicine are used, and medicine is learnt from other's strong points to offset one's weaknesses, and work in coordination with the performance antibacterial and anti-inflammation functions, and produce remarkable result at treatment on some inflammation.
Summary of the invention: purpose of the present invention, be that with Radix Tinosporae, Rhizoma Paridis be raw material, develop a kind of Chinese patent medicine that is mainly used in the treatment genitourinary system.
Concentrate on studies through the inventor is clinical for many years, invented " king lose poison ", with Radix Tinosporae and Rhizoma Paridis collocation, the treatment genito-urinary system digestive system inflammation of unifying, effect is remarkable.Rhizoma Paridis has another name called Typhonium divaricatum (L.) Decne, put down in writing according to " Chinese medicine voluminous dictionary " and " newly organized Chinese medicinal herbal ", Rhizoma Paridis has hemostasis, antibiotic, analgesia, calmness, cough-relieving, relievings asthma and antitumaous effect, to staphylococcus aureus and various pathogens with to the Asia influenza A virus stronger inhibitory action is arranged, can treat parotitis, chronic hepatitis B, acute cholecystitis, encephalitis B etc., and can delay only cancer pain, Rhizoma Paridis is the same with Radix Tinosporae, has the function of the multiple inflammation of treatment equally.Though nature and flavor and effect from Chinese herbal medicine, Radix Tinosporae and Rhizoma Paridis all have characteristics cold in nature and effects for removing toxic heat, can both Broadspectrum antiphlogistic antibiotic, but analyze from its chemical analysis, it is different that the drug main of Radix Tinosporae and Rhizoma Paridis is wanted active ingredient, it is alkaloid that the Radix Tinosporae drug main is wanted active ingredient, and the Rhizoma Paridis drug main to want active ingredient be steroidal saponin, and contain ecdyson and daucosterol, perhaps be because both drug mains are wanted the active ingredient difference, two kinds of medicines are used, and can reach the inaccessiable antiinflammatory effect of single medicine, play synergism.
The clinical for many years discovery of concentrating on studies of inventor, the effect that " king lose poison " has stronger osmosis and recover wound surface, some organize barrier can to penetrate body, genitourinary system there is unique curative effect, especially remarkable to the curative effect of cervical erosion, prostatitis, peptic ulcer, acute bacillary dysentery, acute and chronic cholecystitis.
Medicine of the present invention is to be made by following raw materials in weight portion:
Radix Tinosporae 10-90 Rhizoma Paridis 90-10
The formula optimization weight portion ratio range of preparation medicine of the present invention is:
Radix Tinosporae 30-70 Rhizoma Paridis 70-30
Optimum weight part proportioning of medicine of the present invention is:
Radix Tinosporae 45-55 Rhizoma Paridis 55-45
It is that exsiccant Radix Tinosporae and Rhizoma Paridis are crushed to 200 orders-400 order respectively that above-mentioned each component is made medicine production method of the present invention, and the powder of two kinds of raw materials is mixed in proportion, and at 100-110 ℃ of sterilization treatment 10-30 minute, makes powder.
Based on powder, can make the dosage form on any pharmaceutics.
The powder called after of patent medicine of the present invention " king's baidu powder "; The capsule called after of patent medicine of the present invention " king lose toxic capsule "; The suppository called after of patent medicine of the present invention " king's antiphlogistic suppository "." king's baidu powder " every parcel contains powder 0.5g, " king lose toxic capsule " every dress powder 0.5g, and " king's antiphlogistic suppository " every contains powder 0.3g.
With product treatment cervical erosion of the present invention (or merging vaginitis and pelvic inflammatory disease), be with the external treatment of holding concurrently for oral administration, every day for oral administration " king lose toxic capsule " 3 times, each 2-3 grain, (as identical with capsule with " king's baidu powder " dosing) uses warm boiled water, and with " king's antiphlogistic suppository " intravaginal plug, once a day, each 1-2 grain; Obey every day 3 times with " king lose toxic capsule " with product of the present invention treatment chronic prostatitis, each 3-4 grain (as usefulness " king's baidu powder ", dosing is identical with capsule) is used warm boiled water.
Medicine of the present invention comprises cervicitis (based on cervical erosion), vaginitis, endometritis, adnexitis, pelvic inflammatory disease, ovarian cyst and cystitis, urethritis, prostatitis, epididymitis, orchitis, spermatitis, vasoligation postoperative pain etc. based on treatment inflammation of genito-urinary system disease.In addition, for peptic ulcer, acute bacillary dysentery, acute and chronic cholecystitis, chronic sinusitis, chronic bronchitis, tuberculosis, encephalitis b virus, varicella zoster virus, parotitis, chronic viral hepatitis B, viral keratitis, venom, phlebitic treatment also have certain curative effect.
Take medicine of the present invention, adult's every day, oral 3-8g can not produce any toxic and side effects.
The specific embodiment: embodiment 1, take by weighing drying and be crushed to 200 orders-400 purpose Radix Tinosporae powder 100g, take by weighing drying and be crushed to 200 orders-400 purpose Rhizoma Paridis 900g, with two kinds of abundant mix homogeneously of powder,, carry out dry sterilization and handle 105 ℃ of insulations 30 minutes, be packetized into parcel after the cooling, every bag 0.5g, inventor's called after " king's baidu powder ", the adult obeys 3 times every day, each 2-3 parcel is used warm boiled water.
Embodiment 2, take by weighing drying and be crushed to 200 orders-400 purpose Radix Tinosporae powder 900g, take by weighing drying and be crushed to 200 orders-400 purpose Rhizoma Paridis 100g, with two kinds of abundant mix homogeneously of powder,, carry out dry sterilization and handle 105 ℃ of insulations 30 minutes, be packetized into parcel after the cooling, every bag 0.5g, inventor's called after " king's baidu powder ", the adult obeys 3 times every day, each 2-3 parcel is used warm boiled water.
Embodiment 3, take by weighing drying and be crushed to 200 orders-400 purpose Radix Tinosporae powder 300g, take by weighing drying and be crushed to 200 orders-400 purpose Rhizoma Paridis 700g, with two kinds of abundant mix homogeneously of powder,, carry out dry sterilization and handle 100-110 ℃ of insulation 30 minutes, be packetized into parcel after the cooling, every parcel 0.5g, inventor's called after " king's baidu powder ", the adult obeys 3 times every day, each 2-3 parcel is used warm boiled water.
Embodiment 4, take by weighing drying and be crushed to 200 orders-400 purpose Radix Tinosporae powder 500g, take by weighing drying and be crushed to 200 orders-400 purpose Rhizoma Paridis 500g, both mix homogeneously 100-110 ℃ of insulation 30 minutes, carry out dry sterilization and handle, be packetized into parcel after the cooling, every parcel 0.5g claims " king's baidu powder ", and the adult obeys 3 times every day, each 3 bags are used warm boiled water.
Medicine adult every day of the present invention, 3-8g for oral administration did not see any toxic and side effects.
Based on powder, in powder, add suitable amount of adhesive such as gelatin etc., compression moulding, drying is made piece agent or stype, and powder is mixed with Mel, and pill is made in sealing wax protection in outside; Powder is incapsulated in the shell, make hard capsule medicament etc.Based on powder, can make the dosage form on any pharmaceutics in a word.Press powder and calculate every day for oral administration 3-4 time, each 0.5g, intravaginal turunda bolt once a day, each two (common 0.6g)
Medicine of the present invention has following characteristics:
1, both oral administration, but external again, for oral administration and external combines, and can obtain good therapeutic effect;
2, broad-spectrum antiseptic: though the present invention develops for treatment inflammation of genito-urinary system disease, but treatment to other organ or tissue's inflammation, as peptic ulcer, bacillary dysentery, acute/chronic colitis, acute and chronic cholecystitis, attached sinusitis, acute and chronic rhinitis, flat body inflammation, gingivitis, laryngitis, acute/chronic bronchitis, periostitis, tuberculosis, encephalitis b, herpes zoster, parotitis, chronic viral hepatitis B, the viral keratitis of choosing of acute and chronic, venom, phlebitic treatment also have certain curative effect.
3, almost without any side effects, the adult obeys 3-8g every day, does not have any influence, also dosage of the present invention maximum every day of 1.5-5g.
4, medicine has strong osmosis and recovers the wound surface effect.
5, good drug efficacy, cost is low, makes simple and convenient.
Clinical effectiveness:
The present invention treats cervical erosion, and the inventor has treated cervical erosion 322 examples with medicine of the present invention, (getting rid of obstinate sexually transmitted disease (STD)s such as syphilis and non-gonococcal infection).The oldest 49 years old, minimum 20 years old, wherein I
0Rotten to the corn 42 examples, II
0Rotten to the corn 125 examples, III
0Rotten to the corn 155 examples.From rotten to the corn type branch, simple property cervical erosion 95 examples in 322 examples; Merging vaginitis and pelvic cavity viscera inflammation (comprise endometritis, adnexitis, pelvic inflammatory disease) 176 examples; Merge hysteromyoma and ovarian cyst 51 examples, to simple property cervical erosion and merging vaginitis and pelvic cavity viscera inflammation effective percentage 100%, cure rate 90% is combined hysteromyoma and ovarian cyst cure rate 90.2%, effective percentage 100%.
The inventor controls prostatitis 32 examples with medicine of the present invention, is married male, and maximum 82 years old, minimum 30 years old, the cystitis of merging 7 examples are wherein arranged, merge epididymitis, spermatitis or orchitis 11 examples, effective percentage 100%, cure rate 81%.
Case 1, what * *, man 82 years old, main road township, Song Tao county bight people from village, peasant.Because of dysuria is about 20 days of " chronic prostatitis " hospitalization in December, 2006 at Song Tao county Meng Xi railway hospital diagnosis, treatment is through not quite clear, do not get better to produce institute and go home, and puts catheter for a long time.Seek medical advice in the inventor in January, 2007, with " king lose toxic capsule " oral medication 5 days, takes out catheter and unobstructed micturition, treatment January and healing.
Case 2, yellow * *, the man, 39 years old, the Song Tao county soil pipe cadre of office was because of suffering from chronic attached sinusitis, chronic rhinitis, chronic laryngitis, chronic bronchitis, chronic cholecystitis, chronic prostatitis more than 3 years.Once repeatedly in well-known hospitalize inside and outside the province, nothing was clearly better, and body resistance disease ability seriously descends.Seek medical advice in the inventor in January, 2007, and oral above-mentioned disease all disappears for major-minor with the symptomatic treatment first quarter moon with " king lose toxic capsule ", obeys first quarter moon again and fully recover.Appear the body stalwartness.
So case is a lot, differs at this and one enumerates.
Claims (8)
1. the Chinese medicine of a Broadspectrum antiphlogistic is characterized in that being made by following raw materials in weight portion:
Radix Tinosporae 10-90 Rhizoma Paridis 90-10.
2. the Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 1 is characterized in that being made by following raw materials in weight portion:
Radix Tinosporae 30-70 Rhizoma Paridis 70-30.
3. the Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 1 is characterized in that being made by following raw materials in weight portion:
Radix Tinosporae 45-55 Rhizoma Paridis 55-45.
4. according to the Chinese medicine of claim 1 or 2 or 3 described a kind of Broadspectrum antiphlogistics, it is characterized in that described medicament is the above a dosage form of any pharmaceutics.
5. the Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 4 is characterized in that described medicament is powder or suppository or tincture or tablet or capsule.
6. the preparation method of Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 5, it is characterized in that exsiccant Radix Tinosporae and Rhizoma Paridis are crushed to 200 orders-400 order respectively, the powder of two kinds of raw materials is mixed in proportion,, make powder at 100-110 ℃ of sterilization treatment 10-30 minute.
7. the preparation method of Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 5 is characterized in that powder cooperated with an amount of binding agent such as gelatin etc. and makes suppository.
8. the preparation method of Chinese medicine of a kind of Broadspectrum antiphlogistic according to claim 5 is characterized in that powder is injected capsule shells makes the hard capsule medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200710077928XA CN101380409A (en) | 2007-09-07 | 2007-09-07 | Broadspectrum antiphlogistic traditional Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA200710077928XA CN101380409A (en) | 2007-09-07 | 2007-09-07 | Broadspectrum antiphlogistic traditional Chinese medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101380409A true CN101380409A (en) | 2009-03-11 |
Family
ID=40460579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA200710077928XA Pending CN101380409A (en) | 2007-09-07 | 2007-09-07 | Broadspectrum antiphlogistic traditional Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101380409A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526642A (en) * | 2012-03-20 | 2012-07-04 | 南宁市品迪生物工程有限公司 | Method for treating prostatitis comprehensively |
| CN104800612A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Anti-inflammatory traditional Chinese medicine |
-
2007
- 2007-09-07 CN CNA200710077928XA patent/CN101380409A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526642A (en) * | 2012-03-20 | 2012-07-04 | 南宁市品迪生物工程有限公司 | Method for treating prostatitis comprehensively |
| CN102526642B (en) * | 2012-03-20 | 2013-12-11 | 南宁市品迪生物工程有限公司 | Method for treating prostatitis comprehensively |
| CN104800612A (en) * | 2015-05-25 | 2015-07-29 | 合肥丰瑞隆生物科技有限公司 | Anti-inflammatory traditional Chinese medicine |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101632827B (en) | Traditional Chinese medicine composition for treating psoriasis and preparation method thereof | |
| CN102526355A (en) | Chinese medicinal compound preparation for resisting virus and treating flu and cold | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN100444863C (en) | Chinese medicine composition for diminishing-inflammation and detoxication and its preparing method and use | |
| CN102512547A (en) | Traditional Chinese medicine composition for treating canine distemper virus and preparation method thereof | |
| CN100400052C (en) | Medicine for treating oral ulcer, gastric ulcer, burn and scald and traumatic infection and preparing method | |
| CN101380409A (en) | Broadspectrum antiphlogistic traditional Chinese medicine | |
| CN101229290A (en) | Chinese traditional medicine compounds for treating common cold and throat irritation, and preparing method thereof | |
| CN101954058A (en) | Medicament for treating pernio | |
| CN101966250A (en) | Externally applied Chinese medicament for treating burn and manufacturing method thereof | |
| CN101134092A (en) | Traditional Chinese medicine compound preparations for treating respiratory disease and method for preparing the same | |
| CN101537037B (en) | Amaranth berberine tablet and preparation method thereof | |
| CN102335373A (en) | Chinese medicinal composition for treating upper respiratory tract infection, and preparation method thereof | |
| CN105362337A (en) | Traditional Chinese medicine composition with functions of clearing heat and removing stasis, preparation and method for preparing traditional Chinese medicine composition and preparation | |
| CN101496836A (en) | Chinese medicinal composition for treating common cold and preparation method thereof | |
| CN103816281A (en) | Traditional Chinese medicine composition for preventing and treating wind-heat common cold | |
| CN100402073C (en) | Medicine for treating disease caused by heat toxin | |
| CN104984125A (en) | Traditional Chinese medicine composition for treating wind-cold tightening superficies type cold | |
| CN1233400C (en) | Fever bringing down formulating for preventing virus and its prepn. method | |
| CN100394967C (en) | Chinese medicine composition for treating wrinary tract disease | |
| CN101934048B (en) | Traditional Chinese medicine compound preparation for treating respiratory disease and preparation method thereof | |
| CN103405503A (en) | Traditional Chinese medicine compound preparation for treating acute mastitis and preparation method thereof | |
| CN102106996A (en) | Antibacterial and antiviral Chinese medicine compound preparation and preparation method thereof | |
| CN107296858B (en) | Antibacterial infection pharmaceutical composition and application thereof | |
| CN100384457C (en) | New application of caulis Polygoni Multiflori |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090311 |